Subtypes of Parkinson's disease: state of the field and future directions

被引:43
|
作者
Marras, Connie [1 ,2 ]
机构
[1] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada
[2] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON M5T 2S8, Canada
关键词
MILD COGNITIVE IMPAIRMENT; SLEEP BEHAVIOR DISORDER; DATA-DRIVEN APPROACH; CLINICAL SUBTYPES; NONMOTOR SYMPTOMS; MOTOR SUBTYPES; HETEROGENEITY; DOMINANT; COHORT; TREMOR;
D O I
10.1097/WCO.0000000000000219
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Previously, outstanding questions have been identified including the relationship of proposed subtypes to etiology, underlying biology, and prognosis. This situation presents an opportunity for major developments in the field. The review summarizes the progress made over the past 1-2 years. Recent findings The etiologic, physiological, and clinical differences between tremor dominant, postural instability gait disorder, and indeterminate phenotypes have been further explored, finding genetic influences, functional imaging and clinical differences. New cluster analyses suggest that nonmotor features are important aspects of Parkinson's disease subtypes, but there was little association found between tremor-dominant /postural instability gait disorder phenotype and nonmotor symptoms. In the cognitive realm, empirically derived subtypes of PD-MCI did not map well onto cognitive subtypes derived using a data-driven approach. In data-driven subtype research, important survival differences between subtypes were identified within the PROPARK database. It will be important to revisit PD-MCI classification to consider subtyping based upon data that relate cognitive phenotype to prognosis. Given the traction that traditional motor subtyping has had in the field it would be of value to consider how nonmotor symptom clusters can be used with or alongside the motor subtypes. Finally, incorporating subtypes into clinical trials remains a significant gap in Parkinson's disease research.
引用
收藏
页码:382 / 386
页数:5
相关论文
共 50 条
  • [1] Future directions in the treatment of Parkinson's disease
    Schapira, Anthony H. V.
    [J]. MOVEMENT DISORDERS, 2007, 22 : S385 - S391
  • [2] Specialized Allied Health Care for Parkinson's Disease: State of the Art and Future Directions
    Sturkenboom, Ingrid H. W. M.
    Talebi, Amir H.
    Maas, Bart R.
    de Vries, Nienke M.
    Darweesh, Sirwan K. L.
    Kalf, Johanna G.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2024, 14 : S193 - S207
  • [3] Closed-Loop Neuromodulation for Parkinson's Disease: Current State and Future Directions
    Kim, Samhwan
    Kang, Seongtak
    Kim, Jinmo
    Lee, Doyoung
    Kim, Sanghee
    Lee, Junghyup
    Jang, Kyung-In
    Oh, Yong-Seok
    Rah, Jong-Cheol
    Huh, Man Seung
    Paek, Sun Ha
    Choi, Ji-Woong
    [J]. IEEE TRANSACTIONS ON MOLECULAR BIOLOGICAL AND MULTI-SCALE COMMUNICATIONS, 2021, 7 (04): : 209 - 223
  • [4] Apomorphine therapy in Parkinson's disease and future directions
    Titova, Nataliya
    Chaudhuri, K. Ray
    [J]. PARKINSONISM & RELATED DISORDERS, 2016, 33 : S56 - S60
  • [5] Adenosine A2A receptor antagonists and Parkinson's disease:: State of the art and future directions
    Simola, N.
    Morelli, M.
    Pinna, A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (15) : 1475 - 1489
  • [6] Probiotics for Parkinson's disease: Current evidence and future directions
    Tan, Ai Huey
    Hor, Jia Wei
    Chong, Chun Wie
    Lim, Shen-Yang
    [J]. JGH OPEN, 2021, 5 (04): : 414 - 419
  • [7] Status and future directions of clinical trials in Parkinson's disease
    Soderbom, Grazyna
    [J]. METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 153 - 188
  • [8] Management of Parkinson's disease - Strategies, pitfalls, and future directions
    Hermanowicz, N
    [J]. POSTGRADUATE MEDICINE, 2001, 110 (06) : 15 - +
  • [9] Air pollution and Parkinson's disease - evidence and future directions
    Palacios, Natalia
    [J]. REVIEWS ON ENVIRONMENTAL HEALTH, 2017, 32 (04) : 303 - 313
  • [10] Immunotherapy in Parkinson's disease: Current status and future directions
    Chatterjee, Diptaman
    Kordower, Jeffrey H.
    [J]. NEUROBIOLOGY OF DISEASE, 2019, 132